These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16638192)

  • 61. [Mechanism of arsenic trioxide induced apoptosis in cultured human lens epithelium cells].
    Zhang H; Liu P; Yu XH; Song Z
    Zhonghua Yan Ke Za Zhi; 2008 Oct; 44(10):916-20. PubMed ID: 19176121
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Downregulation of P-gp, Ras and p-ERK1/2 contributes to the arsenic trioxide-induced reduction in drug resistance towards doxorubicin in gastric cancer cell lines.
    Zhao YY; Yu L; Liu BL; He XJ; Zhang BY
    Mol Med Rep; 2015 Nov; 12(5):7335-43. PubMed ID: 26459009
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
    Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
    Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
    Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ
    Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Study on the sensitivity of leukemic cells to arsenic trioxide enhanced by targeted suppression of mIRNA-21].
    Li YM; Gu JY; Zhu XJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Feb; 30(2):170-3. PubMed ID: 20462046
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diarsenic and tetraarsenic oxide inhibit cell cycle progression and bFGF- and VEGF-induced proliferation of human endothelial cells.
    Woo SH; Park MJ; An S; Lee HC; Jin HO; Lee SJ; Gwak HS; Park IC; Hong SI; Rhee CH
    J Cell Biochem; 2005 May; 95(1):120-30. PubMed ID: 15723287
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Effect of arsenic trioxide on VEGF/R and MMP-2, 9 expressed in K562 cells].
    Zhang Y; Zhang JD; Gu J; Ma L; Shen WG; Wang XL; Chen H
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):107-10. PubMed ID: 17650671
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bone marrow stromal cells from myeloma patients support the growth of myeloma stem cells.
    Feng Y; Wen J; Mike P; Choi DS; Eshoa C; Shi ZZ; Zu Y; Chang CC
    Stem Cells Dev; 2010 Sep; 19(9):1289-96. PubMed ID: 20121456
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1.
    Fowler JA; Mundy GR; Lwin ST; Edwards CM
    Cancer Res; 2012 May; 72(9):2183-9. PubMed ID: 22374979
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-term bone marrow cultured stromal cells regulate myeloma tumour growth in vitro: studies with primary tumour cells and LTBMC-dependent cell lines.
    Bloem AC; Lamme T; de Smet M; Kok H; Vooijs W; Wijdenes J; Boom SE; Lokhorst HM
    Br J Haematol; 1998 Jan; 100(1):166-75. PubMed ID: 9450806
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells.
    Ara T; Song L; Shimada H; Keshelava N; Russell HV; Metelitsa LS; Groshen SG; Seeger RC; DeClerck YA
    Cancer Res; 2009 Jan; 69(1):329-37. PubMed ID: 19118018
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Detection of gene expression alteration of myeloma cells treated with arsenic trioxide].
    Li CL; Chen SL; Chen WM; Liu JZ; Xiao B; Zhang HB
    Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):209-13. PubMed ID: 15949261
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Melphalan exposure induces an interleukin-6 deficit in bone marrow stromal cells and osteoblasts.
    Rellick SL; Piktel D; Walton C; Hall B; Petros W; Fortney JE; Gencheva M; Denvir J; Hobbs G; Craig M; Gibson LF
    Cytokine; 2012 May; 58(2):245-52. PubMed ID: 22356805
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel therapies for multiple myeloma.
    Hayashi T; Hideshima T; Anderson KC
    Br J Haematol; 2003 Jan; 120(1):10-7. PubMed ID: 12492571
    [No Abstract]   [Full Text] [Related]  

  • 75. Evaluation of chemosensitivity of human bone marrow stromal cells--differences between common chemotherapeutic drugs.
    Schmidmaier R; Baumann P; Emmerich B; Meinhardt G
    Anticancer Res; 2006; 26(1A):347-50. PubMed ID: 16475716
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Anti-angiogenic effect of arsenic trioxide in lung cancer via inhibition of endothelial cell migration, proliferation and tube formation.
    Yang MH; Chang KJ; Zheng JC; Huang H; Sun GY; Zhao XW; Li B; Xiu QY
    Oncol Lett; 2017 Sep; 14(3):3103-3109. PubMed ID: 28928847
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells.
    Silva A; Jacobson T; Meads M; Distler A; Shain K
    J Vis Exp; 2015 Jul; (101):e53070. PubMed ID: 26274375
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Effect of arsenic trioxide on bone marrow stromal cells of patients with multiple myeloma].
    Tan J; Liu T; Zhu HL; Meng WT; Yu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):258-61. PubMed ID: 16638192
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Arsenic trioxide inhibits growth of human multiple myeloma cells in the bone marrow microenvironment.
    Hayashi T; Hideshima T; Akiyama M; Richardson P; Schlossman RL; Chauhan D; Munshi NC; Waxman S; Anderson KC
    Mol Cancer Ther; 2002 Aug; 1(10):851-60. PubMed ID: 12492118
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Mechanism of arsenic trioxide-induced cytotoxicity on multiple myeloma cells].
    Chen YB; Hou J; Fu WJ; Ding SQ; Wang DX; Yuan ZG; Kong XT
    Ai Zheng; 2003 Dec; 22(12):1276-9. PubMed ID: 14693051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.